As of Aug 28
| -0.0287 / -7.38%|
The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.75, with a high estimate of 2.00 and a low estimate of 1.50. The median estimate represents a +386.11% increase from the last price of 0.36.
The current consensus among 2 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.